T. Rowe Price Health Sciences Fund, Inc. - PRHSX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ethos Financial Group, LLC | History | Reduced | 2,438 | 203 | 0.01% | 0.02% | 1 | -79 | -3.14% | Q4 2025 | Jan 20, 2026 |
| Westside Investment Management, Inc. | History | No change | 1,467 | 122 | 0.02% | 0.02% | 2 | 0 | 0.0% | Q4 2025 | Jan 23, 2026 |
| Coston, McIsaac & Partners | History | Added to | 790 | 66 | 0.02% | 0.01% | 3 | +84 | 11.9% | Q4 2025 | Feb 03, 2026 |
| Financial Gravity Asset Management, Inc. | History | Added to | 122 | 10 | 0.0% | 0.0% | 4 | +13 | 11.93% | Q4 2025 | Feb 13, 2026 |
| Blue Edge Capital, LLC | History | Closed out | 0 | 0 | — | 0.03% | — | -2,918 | -100.0% | Q3 2025 | Nov 12, 2025 |